Related Experiment Video

Updated: Jul 5, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Caspases inhibition decreases neurological sequelae in meningitis

Jose Irazuzta1, Robert K Pretzlaff, Basilia Zingarelli

  • 1University of Florida at Jacksonville, Wolfson's Children Hospital, Jacksonville, FL, USA. Irazuzta@aol.com

Critical Care Medicine
|April 25, 2008
PubMed
Abstract

Insights

Sustained caspase inhibition with BAF improved cognitive function and reduced neurological damage in rats with bacterial meningitis. This treatment effectively lowered caspase 3 activation, a key marker of brain injury.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Infectious Diseases

Background:

  • Bacterial meningitis can lead to significant brain injury and long-term neurological deficits.
  • Caspase activation plays a critical role in the inflammatory and apoptotic processes contributing to meningitis-induced brain damage.

Purpose of the Study:

  • To investigate the therapeutic potential of sustained caspase inhibition during the acute phase of meningitis-induced brain injury.
  • To assess the impact of a caspase inhibitor on neurobehavioral outcomes in a rat model.

Main Methods:

  • A randomized prospective animal study was conducted using male Wistar rats.
  • Meningitis was induced via basilar cistern inoculation; animals received either Bocaspartyl (OMe)-fluoromethyketone (BAF) or placebo for 4 days alongside antibiotics.
  • Neurobehavioral performance was evaluated for 3 weeks post-treatment, with caspase 3 activity assessed in a subgroup.

Main Results:

  • BAF treatment significantly reduced caspase 3 activation in rats with meningitis.
  • No significant differences in motor deficits were observed between infected groups.
  • Cognitive performance was notably improved in the BAF-treated group compared to placebo.

Conclusions:

  • Sustained systemic administration of BAF effectively inhibits caspase 3 activation in a rat model of bacterial meningitis.
  • This caspase inhibition strategy demonstrates potential in decreasing neurological sequelae following meningitis.

More Related Videos

Quantification of Immunostained Caspase-9 in Retinal Tissue05:18

Quantification of Immunostained Caspase-9 in Retinal Tissue

Published on: July 25, 2022

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...